Metabolic considerations of drugs in the treatment of allergic diseases

Author： García-Martín Elena Canto Gabriela Agúndez José AG

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.11, 2013-11, pp. : 1437-1452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigational drugs for the treatment of allergic rhinitis

By Castillo Jamee Dimov Vesselin

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 6, 2014-06 ,pp. : 823-836

Informa Healthcare

Access to resources Recommend Favorite

Immunomodulatory Treatment Strategies for Allergic Diseases

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 1, 2003-03 ,pp. : 31-46

Bentham Science Publishers

Access to resources Recommend Favorite

New strategies in the treatment and prevention of allergic diseases

By Haitchi Hans Michael Holgate Stephen T

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 2, 2004-02 ,pp. : 107-124

Informa Healthcare

Access to resources Recommend Favorite

Recent Progress in Work on PGD2 Antagonists for Drugs Targeting Allergic Diseases

Current Pharmaceutical Design, Vol. 10, Iss. 28, 2004-11 ,pp. : 3533-3538

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolic and toxicological considerations of newly approved prostate cancer drugs

By Tsao Che-Kai Liaw Bobby Yee Tiffany Galsky Matthew D Oh William K

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 7, 2013-07 ,pp. : 835-846

Informa Healthcare

Access to resources Recommend Favorite